Countdown to Hepatitis Elimination: Early Testing Saves Lives
World Hepatitis Day: Early Screening Breaks the "Hepatitis-Liver Cancer" Chain for 110 Million
Keywords: #WorldHepatitisDay #HepatitisScreening #LiverCancerPrevention #LiverFibrosisTest #EarlyDiagnosis #HepatitisBTest #HepatitisCTest #FreeScreening #LiverCancerScreening
July 28 Campaign Theme: "Countdown to Hepatitis Elimination: Early Testing Saves Lives"
— WHO Global Initiative to Eliminate Viral Hepatitis by 2030
The Silent Epidemic: Three Critical Gaps in Hepatitis Control
WHO data reveals:
🌍 2.8 billion people worldwide risk liver damage, with 110 million undiagnosed HbV/HCV infections
⏰ 90% of liver cancers stem from uncontrolled hepatitis progression
"One hepatitis-related death occurs every 30 seconds, yet 90% of cases are treatable when caught early."
— Director, WHO Global Hepatitis Programme
What is Hepatitis?
Hepatitis means inflammation of the liver and is usually caused by a virus. The most common viruses are Hepatitis A, B and C. The liver is important because it has over 500 functions in our body including helping us to digest food, and aids us in taking medication into our body. Needless to say, it’s pretty important to helping us stay healthy.
The Three Common Types
- Hepatitis A is spread through fecal matter (poop). Usually through contaminated water systems or from someone not washing their hands properly and then preparing food.
- Hepatitis B is transmitted through blood or sex fluids
Often the body can fight off an infection of A or B on it’s own. There is also a vaccine available to prevent both of these infections.
- Hepatitis C does not have a vaccine. It is transmitted through sharing blood. This includes risks such as sharing needles, but also things like sharing personal health hygiene items including toothbrushes, shaving tools, and nail clippers.
Turning the Tide: Next-Generation Screening Technology
Traditional Limitations vs. Modern Solutions
| Challenge | Innovation |
|---|---|
| 50% early fibrosis missed 4-panel #LiverFibrosisTest | Nano-fluorescence Lamuno™ |
| Invasive biopsy risks | #POCT results in 10 min |
| 3-5 day lab turnaround | Aehealth Lamuno X/Pro/Plus Advancements |
✅ Combined #HepatitisBTest and #HepatitisCTest
✅ 92.7% fibrosis prediction accuracy (2024 trial)
✅ Portable units enable #CommunityScreening





Phone
Send Email
whatsapp
Facebook
Youtube








